154 related articles for article (PubMed ID: 8219192)
1. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia.
Farese AM; Williams DE; Seiler FR; MacVittie TJ
Blood; 1993 Nov; 82(10):3012-8. PubMed ID: 8219192
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia.
MacVittie TJ; Farese AM; Patchen ML; Myers LA
Blood; 1994 Oct; 84(8):2515-22. PubMed ID: 7919369
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates.
Stahl CP; Winton EF; Monroe MC; Haff E; Holman RC; Myers L; Liehl E; Evatt BL
Blood; 1992 Nov; 80(10):2479-85. PubMed ID: 1421371
[TBL] [Abstract][Full Text] [Related]
6. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
[TBL] [Abstract][Full Text] [Related]
7. A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy.
O'Shaughnessy JA; Venzon DJ; Gossard M; Noone MH; Denicoff A; Tolcher A; Danforth D; Jacobson J; Keegan P; Miller L; Chow C; Goldspiel B; Cowan KH
Blood; 1995 Oct; 86(8):2913-21. PubMed ID: 7579383
[TBL] [Abstract][Full Text] [Related]
8. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
[TBL] [Abstract][Full Text] [Related]
9. Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin.
Brugger W; Frisch J; Schulz G; Pressler K; Mertelsmann R; Kanz L
J Clin Oncol; 1992 Sep; 10(9):1452-9. PubMed ID: 1517788
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates.
Zeidler C; Kanz L; Hurkuck F; Rittmann KL; Wildfang I; Kadoya T; Mikayama T; Souza L; Welte K
Blood; 1992 Dec; 80(11):2740-5. PubMed ID: 1280477
[TBL] [Abstract][Full Text] [Related]
12. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates.
Mayer P; Valent P; Schmidt G; Liehl E; Bettelheim P
Blood; 1989 Aug; 74(2):613-21. PubMed ID: 2665851
[TBL] [Abstract][Full Text] [Related]
13. Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia.
Farese AM; Herodin F; McKearn JP; Baum C; Burton E; MacVittie TJ
Blood; 1996 Jan; 87(2):581-91. PubMed ID: 8555480
[TBL] [Abstract][Full Text] [Related]
14. A GM-CSF/IL-3 fusion protein promotes neutrophil and platelet recovery in sublethally irradiated rhesus monkeys.
Williams DE; Dunn JT; Park LS; Frieden EA; Seiler FR; Farese AM; Macvittie TJ
Biotechnol Ther; 1993; 4(1-2):17-29. PubMed ID: 8374510
[TBL] [Abstract][Full Text] [Related]
15. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Wu HH; Talpaz M; Champlin RE; Pilat SR; Kurzrock R
Cancer; 2003 Dec; 98(11):2410-9. PubMed ID: 14635076
[TBL] [Abstract][Full Text] [Related]
16. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
[TBL] [Abstract][Full Text] [Related]
17. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression.
MacVittie TJ; Farese AM; Smith WG; Baum CM; Burton E; McKearn JP
Blood; 2000 Feb; 95(3):837-45. PubMed ID: 10648394
[TBL] [Abstract][Full Text] [Related]
18. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
Kovacs CJ; Evans MJ; Daly BM; Thomas-Patterson D; Johnke RM; Powell DS
J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
Patchen ML; Fischer R; MacVittie TJ
Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
[TBL] [Abstract][Full Text] [Related]
20. Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSF.
Rosenfeld CS; Bolwell B; LeFever A; Taylor R; List A; Fay J; Collins R; Andrews F; Pallansch P; Schuster MW; Resta D; Levitt D; Nemunaitis J
Bone Marrow Transplant; 1996 Feb; 17(2):179-83. PubMed ID: 8640163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
